Energy & Commerce Subcommittee on Health Hearing: Securing Our Nation’s Prescription Drug Supply Chain
Background: This hearing will focus on the importance of securing the downstream pharmaceutical supply chain, which includes manufacturers, wholesale distributors, pharmacies, repackagers and third-party logistics providers. In order to ensure that counterfeit or stolen drugs do not enter the supply chain and harm patients, States have passed laws that require, or will require, those involved in the downstream supply chain to keep pedigrees or transaction histories of drugs. Some believe that these differing State requirements should be replaced with a reasonable, practical and feasible Federal policy.
A full overview of the hearing including witness testimony is available on the committee website.